Cross-source evidence timeline

Difelikefalin research timeline

Follow 24 selected, directly cited source records from January 27, 2020 through November 9, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

24Selected records
7Source years
3Evidence lanes
November 9, 2026Latest source date

Source year

2026

7 records
  1. Literature metadata

    New Drugs Update: Finerenone, Difelikefalin, and Avacopan.↗

    PubMed lists PMID 35337427 in The Senior care pharmacist as Journal Article, with publication-date metadata of 2022-04-01 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT06593392↗

    PeptideScanner retained ClinicalTrials.gov record NCT06593392 at 2026-11-15T21:56:33.343Z. Its registry update date was 2026-10-23, and PeptideScanner's reviewed identity mapping was difelikefalin.↗

  3. Regulatory

    Drugs@FDA application ANDA220919↗

    The official Drugs@FDA dataset lists original submission 1 for ANDA 220919 with status AP dated 2026-08-31, and names difelikefalin acetate among the application record's active ingredients.↗

  4. Literature metadata

    Difelikefalin in Black/African American Hemodialysis Patients with Moderate-to-Severe Pruritus: Post hoc Analysis of KALM-1 and KALM-2.↗

    PubMed lists PMID 38253036 in American journal of nephrology as Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-01-22 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    A Phase 3 Trial of Difelikefalin in Hemodialysis Patients with Pruritus.↗

    PubMed lists PMID 31702883 in The New England journal of medicine as Clinical Trial, Phase III, Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, and 1 more PubMed publication type, with publication-date metadata of 2019-11-08 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Phase 2 Trial of Difelikefalin in Notalgia Paresthetica.↗

    PubMed lists PMID 36780675 in The New England journal of medicine as Randomized Controlled Trial, Clinical Trial, Phase II, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-02-09 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    Pruritus Severity and Serum Phosphate in CKD: A Post Hoc Analysis of Difelikefalin Studies.↗

    PubMed lists PMID 39037824 in Kidney360 as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07-22 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2025

2 records
  1. Literature metadata

    Difelikefalin for Hemodialysis Patients with Pruritus in Japan.↗

    PubMed lists PMID 38320524 in NEJM evidence as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2023-10-17 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Difelikefalin in the treatment of hemodialysis patients with pruritus: a systematic review and meta-analysis.↗

    PubMed lists PMID 39712488 in Frontiers in pharmacology as Journal Article, Systematic Review, with publication-date metadata of 2024-12-06 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2024

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT03617536↗

    PeptideScanner retained ClinicalTrials.gov record NCT03617536 at 2026-11-15T21:56:33.343Z. Its registry update date was 2024-01-24, and PeptideScanner's reviewed identity mapping was difelikefalin.↗

Source year

2023

5 records
  1. Regulatory

    Federal Register notice 2023-26106↗

    The Federal Register published notice 2023-26106, attributed to FDA and its parent HHS department, on 2023-11-28. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; Korsuva,” and PeptideScanner's exact reviewed identity mapping connects the document to Difelikefalin.↗

  2. Literature metadata

    Difelikefalin in Hemodialysis Patients with Pruritus.↗

    PubMed lists PMID 32433845 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Difelikefalin in Hemodialysis Patients with Pruritus.↗

    PubMed lists PMID 32433846 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Difelikefalin in Hemodialysis Patients with Pruritus.↗

    PubMed lists PMID 32433847 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Regulatory

    Federal Register notice 2023-10710↗

    The Federal Register published notice 2023-10710, attributed to FDA and its parent HHS department, on 2023-05-19. Its official title is “Product-Specific Guidances; Draft and Revised Draft Guidances for Industry; Availability,” and PeptideScanner's exact reviewed identity mapping connects the document to Difelikefalin.↗

Source year

2022

3 records
  1. Clinical trials

    ClinicalTrials.gov record NCT05533008↗

    PeptideScanner retained ClinicalTrials.gov record NCT05533008 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-09-08, and PeptideScanner's reviewed identity mapping was difelikefalin.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03422653↗

    PeptideScanner retained ClinicalTrials.gov record NCT03422653 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT03636269↗

    PeptideScanner retained ClinicalTrials.gov record NCT03636269 at 2026-11-15T21:56:33.343Z. Its registry update date was 2022-04-26, and PeptideScanner's reviewed identity mapping was difelikefalin.↗

Source year

2021

4 records
  1. Literature metadata

    Difelikefalin Acetate.↗

    PubMed lists PMID 34849553 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2022-01-01 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT03998163↗

    PeptideScanner retained ClinicalTrials.gov record NCT03998163 at 2026-11-15T21:56:33.343Z. Its registry update date was 2021-10-15, and PeptideScanner's reviewed identity mapping was difelikefalin.↗

  3. Regulatory

    Drugs@FDA application NDA214916↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 214916 with status AP dated 2021-08-23, and names difelikefalin acetate among the application record's active ingredients.↗

  4. Literature metadata

    An evaluation of difelikefalin as a treatment option for moderate-to-severe pruritus in end stage renal disease.↗

    PubMed lists PMID 33190563 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2020-12-14 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2020

2 records
  1. Literature metadata

    Difelikefalin in Hemodialysis Patients with Pruritus. Reply.↗

    PubMed lists PMID 32433848 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2020-05-21 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Difelikefalin for the Treatment of Uremic Pruritus.↗

    PubMed lists PMID 31940704 in The New England journal of medicine as Editorial, Comment, with publication-date metadata of 2020-01-16 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗